STOCK TITAN

[Form 4] Rhythm Pharmaceuticals, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Form 144 filing overview: An unidentified stakeholder of The Kroger Co. (KR) has filed a Form 144 indicating an intent to sell up to 26,814 common shares through Fidelity Brokerage Services on or about 11 July 2025. The proposed sale represents roughly 0.004 % of Kroger’s 661.2 million shares outstanding and carries an aggregate market value of US$1.89 million.

Source of shares: All shares were acquired via restricted-stock vesting between 2015 and 2023 as part of compensation agreements with the issuer. No other share sales have been reported by the filer in the past three months.

Key takeaways for investors:

  • The filing signals a modest insider-initiated liquidity event rather than a major divestment.
  • The absence of additional recent sales and the small percentage of total shares outstanding limit the potential market impact.
  • No material adverse information is asserted by the filer, as certified in the Form 144 representation.

Panoramica sulla presentazione del Modulo 144: Un azionista non identificato di The Kroger Co. (KR) ha presentato un Modulo 144 indicando l'intenzione di vendere fino a 26.814 azioni ordinarie tramite Fidelity Brokerage Services intorno al 11 luglio 2025. La vendita proposta rappresenta circa lo 0,004% delle 661,2 milioni di azioni in circolazione di Kroger e ha un valore di mercato aggregato di 1,89 milioni di dollari USA.

Origine delle azioni: Tutte le azioni sono state acquisite tramite il consolidamento di azioni vincolate tra il 2015 e il 2023, nell'ambito di accordi di compensazione con l'emittente. Non sono state segnalate altre vendite di azioni da parte del dichiarante negli ultimi tre mesi.

Punti chiave per gli investitori:

  • La presentazione indica un evento di liquidità modesto avviato da un insider piuttosto che una dismissione significativa.
  • L'assenza di ulteriori vendite recenti e la piccola percentuale rispetto al totale delle azioni in circolazione limitano l'impatto potenziale sul mercato.
  • Il dichiarante non segnala informazioni avverse rilevanti, come certificato nella dichiarazione del Modulo 144.

Resumen de la presentación del Formulario 144: Un accionista no identificado de The Kroger Co. (KR) ha presentado un Formulario 144 indicando la intención de vender hasta 26,814 acciones ordinarias a través de Fidelity Brokerage Services alrededor del 11 de julio de 2025. La venta propuesta representa aproximadamente el 0.004% de las 661.2 millones de acciones en circulación de Kroger y tiene un valor de mercado agregado de 1.89 millones de dólares estadounidenses.

Origen de las acciones: Todas las acciones fueron adquiridas mediante la consolidación de acciones restringidas entre 2015 y 2023 como parte de acuerdos de compensación con el emisor. No se han reportado otras ventas de acciones por parte del declarante en los últimos tres meses.

Puntos clave para los inversores:

  • La presentación señala un evento de liquidez modesto iniciado por un insider, en lugar de una desinversión importante.
  • La ausencia de ventas adicionales recientes y el pequeño porcentaje del total de acciones en circulación limitan el impacto potencial en el mercado.
  • No se afirma información adversa material por parte del declarante, según lo certificado en la representación del Formulario 144.

서식 144 제출 개요: The Kroger Co. (KR)의 신원 미상의 주주가 Fidelity Brokerage Services를 통해 2025년 7월 11일경 최대 26,814주 보통주 매도 의향을 나타내는 서식 144를 제출했습니다. 제안된 매도 물량은 Kroger의 발행 주식 6억 6,120만 주 중 약 0.004%에 해당하며, 총 시장 가치가 미화 189만 달러에 달합니다.

주식 출처: 해당 주식은 2015년부터 2023년까지 제한 주식 권리 확정에 따라 보상 계약의 일환으로 취득된 것입니다. 제출자는 지난 3개월간 다른 주식 매도 내역을 보고하지 않았습니다.

투자자를 위한 주요 시사점:

  • 이번 제출은 주요 매각보다는 내부자에 의한 소규모 유동성 이벤트를 나타냅니다.
  • 최근 추가 매도 내역이 없고 전체 발행 주식 대비 비중이 적어 시장에 미치는 영향은 제한적입니다.
  • 서식 144 진술서에 인증된 바와 같이 제출자는 중대한 부정적 정보를 제시하지 않았습니다.

Vue d'ensemble du dépôt du Formulaire 144 : Un actionnaire non identifié de The Kroger Co. (KR) a déposé un Formulaire 144 indiquant une intention de vendre jusqu'à 26 814 actions ordinaires via Fidelity Brokerage Services aux alentours du 11 juillet 2025. La vente proposée représente environ 0,004 % des 661,2 millions d'actions en circulation de Kroger et correspond à une valeur marchande globale de 1,89 million de dollars US.

Origine des actions : Toutes les actions ont été acquises par attribution d'actions restreintes entre 2015 et 2023 dans le cadre d'accords de rémunération avec l'émetteur. Aucun autre vente d'actions n'a été signalée par le déclarant au cours des trois derniers mois.

Points clés pour les investisseurs :

  • Le dépôt signale un événement de liquidité modéré initié par un initié plutôt qu'une cession importante.
  • L'absence de ventes récentes supplémentaires et la faible proportion du total des actions en circulation limitent l'impact potentiel sur le marché.
  • Aucune information défavorable majeure n'est signalée par le déclarant, comme certifié dans la déclaration du Formulaire 144.

Überblick zur Einreichung von Formular 144: Ein nicht identifizierter Aktionär von The Kroger Co. (KR) hat ein Formular 144 eingereicht, das die Absicht angibt, bis zu 26.814 Stammaktien über Fidelity Brokerage Services etwa am 11. Juli 2025 zu verkaufen. Der geplante Verkauf entspricht etwa 0,004% der 661,2 Millionen ausstehenden Kroger-Aktien und hat einen gesamtmarktwert von 1,89 Millionen US-Dollar.

Herkunft der Aktien: Alle Aktien wurden zwischen 2015 und 2023 durch die Freigabe von eingeschränkten Aktien im Rahmen von Vergütungsvereinbarungen mit dem Emittenten erworben. In den letzten drei Monaten wurden vom Einreicher keine weiteren Aktienverkäufe gemeldet.

Wichtige Erkenntnisse für Investoren:

  • Die Einreichung signalisiert ein moderates Insider-Liquiditätsereignis und keine größere Veräußerung.
  • Das Fehlen weiterer kürzlicher Verkäufe und der geringe Anteil an den ausstehenden Aktien begrenzen die potenziellen Marktauswirkungen.
  • Der Einreicher gibt keine wesentlichen negativen Informationen an, wie im Formular 144 bestätigt.
Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider Form 144 (26.8k shares, $1.9 m) – negligible dilution or signaling risk for KR investors.

The proposed sale amounts to four one-thousandths of a percent of Kroger’s float, far below any threshold likely to pressure share price or alter ownership structure. Because the stock was earned via long-term compensation plans, the transaction looks like routine diversification, not a strategic exit. With no accompanying operational disclosures, I view the filing as administratively neutral.

TL;DR: Routine Rule 144 notice; governance implications minimal.

The form contains all required attestations, including the statement that the filer possesses no undisclosed material information. There are no signs of aggregation triggers or past-period sales. From a governance standpoint, the process adheres to Rule 144 and 10b5-1 safeguards, so I assign a neutral impact.

Panoramica sulla presentazione del Modulo 144: Un azionista non identificato di The Kroger Co. (KR) ha presentato un Modulo 144 indicando l'intenzione di vendere fino a 26.814 azioni ordinarie tramite Fidelity Brokerage Services intorno al 11 luglio 2025. La vendita proposta rappresenta circa lo 0,004% delle 661,2 milioni di azioni in circolazione di Kroger e ha un valore di mercato aggregato di 1,89 milioni di dollari USA.

Origine delle azioni: Tutte le azioni sono state acquisite tramite il consolidamento di azioni vincolate tra il 2015 e il 2023, nell'ambito di accordi di compensazione con l'emittente. Non sono state segnalate altre vendite di azioni da parte del dichiarante negli ultimi tre mesi.

Punti chiave per gli investitori:

  • La presentazione indica un evento di liquidità modesto avviato da un insider piuttosto che una dismissione significativa.
  • L'assenza di ulteriori vendite recenti e la piccola percentuale rispetto al totale delle azioni in circolazione limitano l'impatto potenziale sul mercato.
  • Il dichiarante non segnala informazioni avverse rilevanti, come certificato nella dichiarazione del Modulo 144.

Resumen de la presentación del Formulario 144: Un accionista no identificado de The Kroger Co. (KR) ha presentado un Formulario 144 indicando la intención de vender hasta 26,814 acciones ordinarias a través de Fidelity Brokerage Services alrededor del 11 de julio de 2025. La venta propuesta representa aproximadamente el 0.004% de las 661.2 millones de acciones en circulación de Kroger y tiene un valor de mercado agregado de 1.89 millones de dólares estadounidenses.

Origen de las acciones: Todas las acciones fueron adquiridas mediante la consolidación de acciones restringidas entre 2015 y 2023 como parte de acuerdos de compensación con el emisor. No se han reportado otras ventas de acciones por parte del declarante en los últimos tres meses.

Puntos clave para los inversores:

  • La presentación señala un evento de liquidez modesto iniciado por un insider, en lugar de una desinversión importante.
  • La ausencia de ventas adicionales recientes y el pequeño porcentaje del total de acciones en circulación limitan el impacto potencial en el mercado.
  • No se afirma información adversa material por parte del declarante, según lo certificado en la representación del Formulario 144.

서식 144 제출 개요: The Kroger Co. (KR)의 신원 미상의 주주가 Fidelity Brokerage Services를 통해 2025년 7월 11일경 최대 26,814주 보통주 매도 의향을 나타내는 서식 144를 제출했습니다. 제안된 매도 물량은 Kroger의 발행 주식 6억 6,120만 주 중 약 0.004%에 해당하며, 총 시장 가치가 미화 189만 달러에 달합니다.

주식 출처: 해당 주식은 2015년부터 2023년까지 제한 주식 권리 확정에 따라 보상 계약의 일환으로 취득된 것입니다. 제출자는 지난 3개월간 다른 주식 매도 내역을 보고하지 않았습니다.

투자자를 위한 주요 시사점:

  • 이번 제출은 주요 매각보다는 내부자에 의한 소규모 유동성 이벤트를 나타냅니다.
  • 최근 추가 매도 내역이 없고 전체 발행 주식 대비 비중이 적어 시장에 미치는 영향은 제한적입니다.
  • 서식 144 진술서에 인증된 바와 같이 제출자는 중대한 부정적 정보를 제시하지 않았습니다.

Vue d'ensemble du dépôt du Formulaire 144 : Un actionnaire non identifié de The Kroger Co. (KR) a déposé un Formulaire 144 indiquant une intention de vendre jusqu'à 26 814 actions ordinaires via Fidelity Brokerage Services aux alentours du 11 juillet 2025. La vente proposée représente environ 0,004 % des 661,2 millions d'actions en circulation de Kroger et correspond à une valeur marchande globale de 1,89 million de dollars US.

Origine des actions : Toutes les actions ont été acquises par attribution d'actions restreintes entre 2015 et 2023 dans le cadre d'accords de rémunération avec l'émetteur. Aucun autre vente d'actions n'a été signalée par le déclarant au cours des trois derniers mois.

Points clés pour les investisseurs :

  • Le dépôt signale un événement de liquidité modéré initié par un initié plutôt qu'une cession importante.
  • L'absence de ventes récentes supplémentaires et la faible proportion du total des actions en circulation limitent l'impact potentiel sur le marché.
  • Aucune information défavorable majeure n'est signalée par le déclarant, comme certifié dans la déclaration du Formulaire 144.

Überblick zur Einreichung von Formular 144: Ein nicht identifizierter Aktionär von The Kroger Co. (KR) hat ein Formular 144 eingereicht, das die Absicht angibt, bis zu 26.814 Stammaktien über Fidelity Brokerage Services etwa am 11. Juli 2025 zu verkaufen. Der geplante Verkauf entspricht etwa 0,004% der 661,2 Millionen ausstehenden Kroger-Aktien und hat einen gesamtmarktwert von 1,89 Millionen US-Dollar.

Herkunft der Aktien: Alle Aktien wurden zwischen 2015 und 2023 durch die Freigabe von eingeschränkten Aktien im Rahmen von Vergütungsvereinbarungen mit dem Emittenten erworben. In den letzten drei Monaten wurden vom Einreicher keine weiteren Aktienverkäufe gemeldet.

Wichtige Erkenntnisse für Investoren:

  • Die Einreichung signalisiert ein moderates Insider-Liquiditätsereignis und keine größere Veräußerung.
  • Das Fehlen weiterer kürzlicher Verkäufe und der geringe Anteil an den ausstehenden Aktien begrenzen die potenziellen Marktauswirkungen.
  • Der Einreicher gibt keine wesentlichen negativen Informationen an, wie im Formular 144 bestätigt.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shulman Joseph

(Last) (First) (Middle)
C/O RHYTHM PHARMACEUTICALS, INC.
222 BERKELEY STREET, 12TH FLOOR

(Street)
BOSTON MA 02116

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RHYTHM PHARMACEUTICALS, INC. [ RYTM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Technical Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/09/2025 M 7,969 A $6.8 16,478 D
Common Stock 07/09/2025 S(1) 3,984 D $75.5649(2) 12,494 D
Common Stock 07/09/2025 S(1) 3,985 D $80 8,509 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $6.8 07/09/2025 M 7,969 (3) 02/08/2032 Common Stock 7,969 $0 11,953 D
Explanation of Responses:
1. The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on August 8, 2024.
2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $75.12 to $75.92 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
/s/ Stephen Vander Stoep, attorney-in-fact for Joseph Shulman 07/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did The Kroger Co. (KR) insider file a Form 144?

The filer plans to sell 26,814 common shares under Rule 144, requiring advance notice to the SEC and the market.

How large is the planned Kroger share sale?

The notice covers 26,814 shares worth about US$1.89 million, or roughly 0.004 % of shares outstanding.

When is the Kroger insider expected to sell the shares?

The approximate sale date disclosed is 11 July 2025.

How were the shares originally acquired by the insider?

All shares originated from restricted-stock vesting events between 2015 and 2023 as part of compensation.

Does the Form 144 mention recent prior sales by the filer?

No. The section on securities sold in the past three months states "Nothing to Report".

Which broker will handle the KR share sale?

Fidelity Brokerage Services LLC, Smithfield, RI, is listed as the executing broker.
Rhythm Pharmaceu

NASDAQ:RYTM

RYTM Rankings

RYTM Latest News

RYTM Latest SEC Filings

RYTM Stock Data

4.30B
61.50M
0.54%
107.82%
8.14%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON